Biotalys Stock: price and insider trades · Belgium

Biotalys belongs to the Health Care sector. Filings by its managers are published through FSMA. The last twelve months, up to 18 October 2026, brought 7 filings signed by 5 insiders.

Both sides are active: 5 purchases worth €3.3M and 2 sales, from 5 insiders and 2 insiders respectively. No amount is published for 6 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Among those who bought: 4 senior executives and 1 board member. One trade stands out by size: a purchase of €3.3M from Agri Investment Fund, disclosed on 21 May 2026, or 2.5% of market capitalisation.

Compared with its exchange (77 companies, median 11 filings), a count of 7 filings is below the norm. The full history, which starts in 2022, counts 39 purchases against 2 sales.

The last insider purchase was made public on 14 September 2026, 34 days ago. Filings reach the FSMA feed a median of 8 days after the trade. The regulation allows three business days to notify a trade (MAR article 19).

Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from FSMA. Past trades are no guide to future returns.